Member Info for Twenty-Four

Over the coming 2-4 years the resources will each be proved up. Ultimately I do not think we will be mining, but assets purchased. Will be aiming to add, on dips. Free float getting smaller too..,,

Very true. "Don't let the tax tail wag the dog".

No Gecko, not animosity. However, perhaps a touch of arrogance.... :-) Hopefully you're wise enough that when you've cashed in your probably large pile of chips you won't be lording it over others. Looking forward to news and yes hopefully a good opportunity to speak to an IFA - as it happens booked for next week anyway.

There will be a reset. Those with spare funds will top up CEO says"Tai-1 has successfully identified helium shows within all three target formations which confirms the presence of a working helium system in the Rukwa Basin. ". Traders will be getting out. One style of investing is to buy shares when drilling/mining starts and sell out before the news each and every time. Here's a good example of how that strategy works.

Level 2, already very steady and lots looking to buy at the lower prices.

Would have to have some sort of radar to pinpoint drones too. 3am in the morning, at sea, not sure you would see anything, even if you were looking out.

Not the clearest, nor the foggiest.

Also in The Times. Grail's work aligns with CIZ. Lung cancer detection not mentioned, although many other cancers are.

Cizzle Biotechnology, a UK based developer of a blood test for the early
detection of a majority of the different forms of lung cancer, is pleased to
announce that it has signed a Memorandum of Understanding ("MoU") with St
George Street Capital ("SGS"), a UK-based medical charity led by a group of
highly decorated academics and ex-pharma executives formed to deliver much
needed treatments to patients. SGS's strategy is to progress existing
clinical assets through Phase II medical trials, before licencing them on for
Phase III trials and commercialisation.

The MoU covers a proposed collaboration between the parties to develop a
companion diagnostic platform for certain therapeutic assets already licenced
to SGS by a large pharma company, which seeks to address unmet clinical needs
in autoimmune disease. A companion diagnostic is a medical device which
provides information that is essential for the safe and effective use of a
corresponding drug. It assists health care professionals determine whether a
particular therapeutic product's benefits to patients will outweigh any
potential serious side effects or risks.

Under the terms of the MOU, and subject to a full commercial contract being
entered into, it is proposed that SGS will pay milestone payments to Cizzle
Biotechnology of up to £1 million, from which the Company will fund the work
to be undertaken to develop the companion diagnostic and any third parties
contracted by Cizzle Biotechnology to assist. SGS is to be responsible for
providing clinical samples, reagents and patient and technical information
and, in addition, will provide regulatory and technical advice on securing the
required regulatory approvals for the companion diagnostic platform. Cizzle
Biotechnology will utilise its existing technology and know-how covering
companion diagnostics in developing the platform.

Further, under the MoU, SGS has agreed to grant Cizzle Biotechnology potential
future royalty payments from the commercialisation of SGS's therapeutic asset
of up to £5 million, plus potentially further payments from the use of the
companion diagnostic. In consideration of this potential royalty stream,
Cizzle Biotechnology has paid £65,000 to SGS on signature of the MOU and will
pay a further £135,000 on entering into a full commercial contract. Any
payments under this royalty are contingent on the successful development of
SGS's therapeutic asset.

Actually managed to pick up 27, 600 shares are 19.1p!

Interestingly £20k of sales vs £286k of purchases over the day, ending flat. Accumulation going on?

I also think "CIZ" could be massive. I doubt that it will be just lung cancer that can be detected early, CIZ could help to early identify a number of be a number of cancers.

I very much doubt AG will sell. Short term now old AIM holders, (not necessarily investors!) will take their money out in the first hours/days, looking for a faster buck elsewhere and disappointed with the lack of return on day 1.
Just a guess. :-) 25% up end of first day of trading?

PUC, Pancontinental Resources rather similar, currently £24m mkt cap. Any others have some examples/comparables?

MarkLong. I'd love a 10 - 100 bag. Have you got a few recent examples where companies have released maiden resource reports and such a dramatic rerate has occured? I was trying to look back and research a few so that I could set my own expectations.

I picked up more the other day. I will continue, if I can find more funds! :-)

Might be longer, since labs are taking more time. Still good news and looking forward to results and report.

Yes, hobione, please elaborate.

Why the interest from Lombard Odier??

Currently the Director's seem to have no shares. Might be cheaper entry price for themselves!